In 2014, approximately 480,000 people developed MDR-TB. 3.3% of new cases and 20% of previously treated patients develop MDR-TB. It was estimated that only 41% of cases were notified that they had MDR-TB in 2014. In low and middle-income countries, access to quality TB services is often limited. Since the beginning of TB CARE II in 2010, TB CARE II has worked to decrease MDR-TB. TB CARE II has: held over 6 trainings on MDR-TB, with more than 307 people attending the trainings, sponsored 7 fellows in PMDT Fellowship program, developed over 4 tools and 2 mHealth apps that brought over 396 downloads and were utilized by over 50 patients, and hosted 42 webinars with more than 1300 people participating in the webinars. Click here for MDR TB fact sheet.
Multi-Drug Resistant TB